grey arrow to go to previous Omnicell webpage or forward to next Omnicell pageBack to Press Release

October 26, 2017

Hackensack Meridian Health Expands Contract with Omnicell for Medication Management Technology

Download PDF

MOUNTAIN VIEW, Calif., Oct. 26, 2017 /PRNewswire/ -- Omnicell, Inc. (NASDAQ: OMCL) today announced that Hackensack Meridian Health has chosen the Company's automated medication management solutions and enterprise services to serve the health care network's pharmacy needs. Hackensack Meridian Health serves New Jersey residents spanning from Bergen to Atlantic counties through its 13 hospitals and more than 140 ambulatory care centers, fitness and wellness centers, home health services, rehabilitation centers, and skilled nursing centers. Hackensack Meridian Health recognizes that having cohesive medication management technology across its healthcare system can play an integral role in improving clinical operations, specifically by promoting patient safety, supply chain efficiencies, and overall standardization efforts.

Omnicell, Inc. logo. (PRNewsFoto/Omnicell, Inc.)

As a nationally accredited health network with four of its hospitals ranked in the top 10 in New Jersey by U.S. News & World Report- including the #1 ranked hospital in the state - Hackensack Meridian Health is dedicated to providing its patients with the highest quality of care. To better serve patients in today's evolving healthcare environment, they are seeking technologies that can be integrated across all facility locations and that have the ability to adapt as technological advancements are made.

In its five recently added facilities, Hackensack Meridian Health is installing Omnicell® XT Automated Dispensing Cabinets, which are part of Omnicell's Unity enterprise platform. This scalable platform enables the XT cabinets to be added to a common database used for Omnicell systems across the health network rather than requiring an all new server infrastructure. This cohesive platform supports safer medication distribution practices and creates efficiencies that enable more time for patient care.

"Patient safety is Hackensack Meridian Health's top priority," said Richard Epstein, vice president of Network Drug Management, Hackensack Meridian Health. "We pride ourselves for being on the cutting edge of technology. The safer medication workflow through interoperability with our electronic health record system is a forward thinking approach that we embrace." 

"As health systems merge, it's important to have a system in place that can centralize information in order to remain financially viable without sacrificing patient safety or quality of care," said J. Christopher Drew, president, North American Automation and Analytics at Omnicell. "We are proud to continue our relationship with Hackensack Meridian Health as they expand to further solidify their presence as one of New Jersey's most prestigious health networks."

About Hackensack Meridian Health

Hackensack Meridian Health is a leading not-for-profit health care organization that is the most comprehensive and truly integrated health care network in New Jersey, offering a complete range of medical services, innovative research and life-enhancing care. Hackensack Meridian Health comprises 13 hospitals, including two academic medical centers, two children's hospitals and nine community hospitals, physician practices, more than 140 ambulatory care centers, surgery centers, home health services, long-term care and assisted living communities, ambulance services, lifesaving air medical transportation, fitness and wellness centers, rehabilitation centers, and urgent care and after-hours centers. Hackensack Meridian Health has 28,000 team members, more than 6,000 physicians and is a distinguished leader in health care philanthropy, committed to the health and well-being of the communities it serves.

The Network's notable distinctions include having one of only five major academic medical centers in the nation to receive Healthgrades America's 50 Best Hospitals Award for five or more consecutive years, the number one hospital in New Jersey as ranked by U.S. News and World Report for a total of four hospitals ranked among the top 10 - more than any other network in New Jersey. The network consistently achieves Magnet® recognition for nursing excellence from the American Nurses Credentialing Center, is the recipient of the John M. Eisenberg Award for Patient Safety and Quality from The Joint Commission and the National Quality Forum, a six-time recipient of Fortune's "100 Best Companies to Work For," one of the "20 Best Workplaces in Health Care" in the nation, and the number one "Best Place to Work for Women." Hackensack Meridian Health is a member of AllSpire Health Partners, an interstate consortium of leading health systems, to focus on the sharing of best practices in clinical care and achieving efficiencies.

The hospitals of Hackensack Meridian Health include: academic medical centers - Hackensack University Medical Center in Hackensack, Jersey Shore University Medical Center in Neptune; children's hospitals - Joseph M. Sanzari Children's Hospital in Hackensack, K. Hovnanian Children's Hospital in Neptune; community hospitals - Ocean Medical Center in Brick, Riverview Medical Center in Red Bank, Mountainside Medical Center in Montclair, Palisades Medical Center in North Bergen, Raritan Bay Medical Center in Perth Amboy, Southern Ocean Medical Center in Manahawkin, Bayshore Medical Center in Holmdel, Raritan Bay Medical Center in Old Bridge, and Pascack Valley Medical Center in Westwood.

For additional information, please visit WWW.HACKENSACKMERIDIANHEALTH.ORG.

About Omnicell

Since 1992, Omnicell (NASDAQ: OMCL) has been inspired to create safer and more efficient ways to manage medications and supplies across all care settings. As a leader in medication and supply dispensing automation, central pharmacy automation, IV robotics, analytics software, and medication adherence and packaging systems, Omnicell is focused on improving care across the entire healthcare continuum—from the acute care hospital setting, to post-acute skilled nursing and long-term care facilities, to the patient's home.

Over 4,000 customers worldwide use Omnicell® automation and analytics solutions to increase operational efficiency, reduce medication errors, deliver actionable intelligence and improve patient safety. Omnicell's innovative medication adherence solutions, used by over 32,000 institutional and retail pharmacies in North America and the United Kingdom, are designed to improve patient adherence to prescriptions, helping to reduce costly hospital readmissions.

Recent Omnicell acquisitions, including Ateb, add distinct capabilities, particularly in central pharmacy, IV robotics, and pharmacy software, creating the broadest medication management product portfolio in the industry.

For more information about Omnicell, Inc. please visit


Editor's Notes:

  1. All Omnicell news releases (financial, acquisitions, products, technology etc.) are issued exclusively by PR Newswire and are immediately thereafter posted on the company's external website,
  2. Omnicell and the Omnicell logo design are registered trademarks of Omnicell, Inc.
  3. All other brand or product names may be trademarks or registered trademarks of their respective companies.


View original content with multimedia:

SOURCE Omnicell, Inc.

News Provided by Acquire Media